MedTrace Logo

Proadrenomedullin and Copeptin in Patients With Septic Shock

NCT03104933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2021-04-02

No results posted yet for this study

Summary

This study evaluates the usefulness of pro-adrenomedullin (precursor of a vasodilatory peptide involved in septic shock pathogenesis) and copeptin (a stable peptide of the arginine vasopressin precursor) to predict, at the moment of septic shock diagnosis or their changes at 6 hours, the vasopressor requirements (measured by inotropic index and vasopressor dependency ratio) and volume requirement for resuscitation.

Conditions

  • Septic Shock

Sponsors & Collaborators

  • Spanish Network for Research in Infectious Diseases

    lead OTHER

Principal Investigators

  • José Garnacho-Montero, MD · Hospital Universitario Virgen Macarena

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2019-09-30
Completion
2021-03-11

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03104933 on ClinicalTrials.gov